Clinical trial
A Parallel Two Arm, Double Blinded Placebo Study, Examining the Efficacy of Sumatriptan With Naprosyn in the Treatment of Migraine With Aura
NCT00893594 is registered in ClinicalTrials.gov with Dent Neurologic Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Parallel Two Arm, Double Blinded Placebo Study, Examining the Efficacy of Sumatriptan With Naprosyn in the Treatment of Migraine With Aura
- Lead sponsor
- Dent Neurologic Institute
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 31, 2010
- Completion date
- December 31, 2015
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.